A mechanistic study indicated that FGF21-induced cardiac protection against DCM is probably mediated by AMPK-induced antioxidative pathway (AKT–GSK3β–Fyn–NRF2) and lipid-lowering pathway (ACC–CPT-1) (Fig. 8). This evidence concerns the gene GSK3B and familial dilated cardiomyopathy.